Galectin-3: A potential new target for upstream therapy of atrial fibrillation. [electronic resource]
- International journal of cardiology Jan 2016
- 1131-2 p. digital
Publication Type: Letter
1874-1754
10.1016/j.ijcard.2015.09.058 doi
Atrial Fibrillation--blood Atrial Remodeling Biomarkers--blood Fibrosis--metabolism Galectin 3--blood Humans Predictive Value of Tests